LG-768

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLG-768
Drug Alias NameTherapeutic vaccine (Lentigen)recombinant viral vector vaccine (Lentigen)LG-768
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLentigen Technology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLentigen Technology Inc
Active IndicationsN/A
Inactive IndicationsLeukemia, Lymphocytic, Chronic, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A